Hanall Pharmaceutical Company, Ltd.

République de Corée

 
Quantité totale PI 18
Rang # Quantité totale PI 83 971
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 679 757

Brevets

Marques

0 0
0 0
18 0
0
 
Dernier brevet 2010 - N,n-dimethyl imidodicarbonimidic...
Premier brevet 2001 - Mutant recombinant adeno-associa...

Derniers inventions, produits et services

2009 Invention Pharmaceutical formulation for treating cardiovascular disease. The present invention provides a ...
2008 Invention Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase ...
Invention N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmac...
Invention Oral administration drug comprising clopidogrel besylate. The present invention relates to clopid...
Invention 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceuti...
Invention Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manu...
Invention N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceuti...
2007 Invention Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor bl...
Invention Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa re...
Invention Combination formulation with controlled release comprising metformin and glimepiride. The present...
Invention Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory. ...
Invention Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium ch...
Invention Furan-2-carboxylic acid derivatives and process for the preparation thereof. This invention relat...
Invention Oral dosage formulations of protease-resistant polypeptides. Oral dosage formulations of the pro...
Invention Modified interferon-beta (ifn-beta) polypeptides. Provided are modified interferon-beta polypept...
Invention Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid mol...
Invention Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium ch...
2006 Invention Compositions for external application, containing adenosyl cobalamin for improvement of skin dise...
Invention Pharmaceutical compositions and formulations of metformin extended release tablets. The present ...
Invention Matrix tablets providing an extended release of metformin. The present invention relates to a met...
Invention Metformin tablet with sustained release and method for preparing the same. The present invention ...
Invention Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptid...
2003 Invention Rational directed protein evolution using two-dimensional rational mutagenesis scanning. Rationa...
Invention High throughput directed evolution of nucleic acids by rational mutagenesis. Method and systems f...
2001 Invention Mutant recombinant adeno-associated viruses. Processes and systems for the high throughput direct...